YOSHITAKAISAKA SuitaJapan

Wcn26 Post edited Speaker Card

29 March 2026

Time	Session

8:10 a.m. 9:10 a.m.	Industry Symposium 3 AkiraNishiyama Moderator Japan MarikoMiyazaki Moderator mamiyaza@venus.dti.ne.jpJapan Urinary Uric Acid Excretion and Kidney Outcome YOSHITAKAISAKA Speaker Japan Uric Acid and Progression of DKD JunWada Speaker Japan 304
5 p.m. 6 p.m.	Industry Symposium 30 YOSHITAKAISAKA Moderator Japan Transformative Insights from the DAPA-CKD Trial: Lessons for the Future of Kidney Care NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 501 - 502

30 March 2026

Time

Session

12:50 p.m.

1:50 p.m.

Industry Symposium 46

YOSHITAKAISAKA Moderator Japan

Welcome and introduction

YOSHITAKAISAKA Moderator Japan
Pathophysiology of C3G and Importance of Early Diagnosis

YOSHITAKAISAKA Moderator Japan
Case studies: Different Patient Profiles

CarlaNester Speaker United States

DavidKavanagh Speaker United Kingdom

Paul Brinkkötter Speaker paul.brinkkoetter@uk-koeln.deGermany
Guidelines and Redefining Standard of Care

YOSHITAKAISAKA Moderator Japan
Audience Q&A

YOSHITAKAISAKA Moderator Japan
Summary and close

YOSHITAKAISAKA Moderator Japan

503